These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 30181563)
1. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification. Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563 [TBL] [Abstract][Full Text] [Related]
2. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes. Rekhi B; Upadhyay P; Ramteke MP; Dutt A Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493 [TBL] [Abstract][Full Text] [Related]
3. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis. Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843 [TBL] [Abstract][Full Text] [Related]
4. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases. Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891 [TBL] [Abstract][Full Text] [Related]
5. A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases. Alaggio R; Zhang L; Sung YS; Huang SC; Chen CL; Bisogno G; Zin A; Agaram NP; LaQuaglia MP; Wexler LH; Antonescu CR Am J Surg Pathol; 2016 Feb; 40(2):224-35. PubMed ID: 26501226 [TBL] [Abstract][Full Text] [Related]
6. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases]. Yang L; Zhang HJ; Yang SJ Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670 [No Abstract] [Full Text] [Related]
7. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood. Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity: Gorunova L; Bjerkehagen B; Micci F; Heim S; Panagopoulos I Cancer Genomics Proteomics; 2020; 17(5):563-569. PubMed ID: 32859634 [TBL] [Abstract][Full Text] [Related]
10. MYOD1 as a prognostic indicator in rhabdomyosarcoma. Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590 [TBL] [Abstract][Full Text] [Related]
11. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621 [TBL] [Abstract][Full Text] [Related]
12. Functional impact and targetability of Choo F; Odintsov I; Nusser K; Nicholson KS; Davis L; Corless CL; Stork L; Somwar R; Ladanyi M; Davis JL; Davare MA Cold Spring Harb Mol Case Stud; 2022 Jan; 8(1):. PubMed ID: 35012940 [TBL] [Abstract][Full Text] [Related]
13. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis]. Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817 [No Abstract] [Full Text] [Related]
14. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma. Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773 [TBL] [Abstract][Full Text] [Related]
15. Biological Role and Clinical Implications of Di Carlo D; Chisholm J; Kelsey A; Alaggio R; Bisogno G; Minard-Colin V; Jenney M; Dávila Fajardo R; Merks JHM; Shipley JM; Selfe JL Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980529 [TBL] [Abstract][Full Text] [Related]